TrialA Second Study of Cytisinicline for Smoking Cessation in Adult Smokers
Trial details
- Registry ID
- NCT05206370
- Phase
- Phase 3
Drug research
Cytisinicline
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Cytisine; cytisine
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersNCT05206370 | Achieve Life Sciences | Phase 3 | Completed | 2023-03-21Actual |
| A Study of Cytisinicline for Smoking Cessation in Adult SmokersNCT04576949 | Achieve Life Sciences | Phase 3 | Completed | 2021-12-23Actual |
| Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersNCT06435221 | Achieve Life Sciences | Phase 3 | Completed | 2025-09-29Actual |
| Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesNCT07392125 | Achieve Life Sciences | Phase 3 | Not yet recruiting | 2026-11-15Estimated |
A Study of Cytisinicline for Smoking Cessation in Adult Smokers
Trial details
- Registry ID
- NCT04576949
- Phase
- Phase 3
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
Trial details
- Registry ID
- NCT06435221
- Phase
- Phase 3
Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes
Trial details
- Registry ID
- NCT07392125
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |